Upon surgical excision of the designated tumor tissues (one xenograft per group of each group, at Day-24 and Day-36), we proceeded to analyze the expression profiles of INTS13 and hnRNPC, alongside key markers indicative of cellular proliferation and apoptosis. This evidence concerns the gene INTS13 and neoplasm.